Valuation : Tasly Pharmaceutical Group Co., Ltd

Market Cap 22.05B 3.28B 2.83B 2.66B 2.43B 4.56B 311B 4.59B 31.47B 12.25B 158B 12.32B 12.05B 525B P/E 2026 *
16.3x
P/E 2027 * 13.7x
Enterprise Value 20.51B 3.05B 2.63B 2.48B 2.26B 4.24B 290B 4.26B 29.27B 11.39B 147B 11.45B 11.21B 488B EV / Sales 2026 *
2.39x
EV / Sales 2027 * 1.75x
Free-Float
47.11%
Yield 2026 *
2.8%
Yield 2027 * 3.5%
1 day+0.54%
1 week+0.07%
Current month+0.54%
1 month-8.44%
3 months+2.93%
6 months+1.86%
Current year-2.06%
1 week 14.56
Extreme 14.56
15.04
1 month 14.56
Extreme 14.56
16.22
Current year 12.9
Extreme 12.9
16.24
1 year 12.9
Extreme 12.9
16.6
3 years 12.24
Extreme 12.24
18
5 years 9.2
Extreme 9.2
18
10 years 9.2
Extreme 9.2
34.22
Manager TitleAgeSince
Chief Executive Officer 54 08/05/2024
Director of Finance/CFO 49 09/07/2018
Chief Investment Officer 45 01/05/2025
Director TitleAgeSince
Director/Board Member 72 02/06/2021
Chairman 54 10/08/2026
Director/Board Member 58 08/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
+0.54%+0.07%-10.60%+5.50% 3.28B
+0.58%+1.36%-14.52%-7.11% 13.45B
+0.50%-0.99%-33.45%-56.57% 4.9B
0.00%-2.66%-8.18%-5.18% 4.52B
+0.69%-0.31%-4.12%-30.38% 3.99B
+0.22%+0.11%-20.89%+2.12% 3.57B
-1.08%+2.65%-0.54%-2.29% 3.51B
+0.87%-1.70%-24.37%-13.70% 2.36B
+0.99%+1.24%-26.89%-15.39% 1.72B
+1.80%+5.12%0.00%-12.91% 1.71B
Average +0.51%-0.32%-14.36%-13.59% 4.3B
Weighted average by Cap. +0.43%-0.19%-14.59%-13.50%

Financials

2026 *2027 *
Net sales 8.59B 1.28B 1.1B 1.04B 945M 1.78B 121B 1.79B 12.26B 4.77B 61.73B 4.8B 4.7B 205B 9.31B 1.39B 1.2B 1.12B 1.02B 1.93B 131B 1.94B 13.29B 5.17B 66.89B 5.2B 5.09B 222B
Net income 1.35B 201M 174M 163M 149M 280M 19.1B 281M 1.93B 751M 9.72B 756M 739M 32.22B 1.61B 240M 207M 195M 177M 334M 22.78B 335M 2.3B 896M 11.59B 901M 882M 38.42B
Net Debt -1.54B -230M -198M -186M -170M -319M -21.8B -321M -2.2B -858M -11.09B -862M -844M -36.77B -5.71B -850M -733M -690M -628M -1.18B -80.66B -1.19B -8.15B -3.17B -41.03B -3.19B -3.12B -136B
Logo Tasly Pharmaceutical Group Co., Ltd
Tasly Pharmaceutical Group Co Ltd is a China-based company principally engaged in the manufacture and distribution of pharmaceutical products. The Company's main businesses include the manufacture and sales of traditional Chinese medicines, chemical preparations, chemical raw materials and biological medicines. The Company's main products include Compound Danshen Dropping Pills, Yangxuenao Granules, Yangxuenao Pills, Qishen Yiqi Dropping Pills, Diqing and Shuilinjia. Its products are used to treat cardiovascular and cerebrovascular diseases, tumors, colds, fevers and liver diseases. The Company mainly distributes its products in the domestic market.
Employees
10,563
Date Price Change Volume
01/09/26 CN¥14.76 +0.54% 12,783,525
31/08/26 CN¥14.68 -1.41% 16,219,537
28/08/26 CN¥14.89 +0.47% 15,263,887
27/08/26 CN¥14.82 +0.34% 13,596,225
26/08/26 CN¥14.77 +0.14% 13,777,567
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
14.76CNY
Average target price
17.29CNY
Spread / Average Target
+17.14%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600535 Stock